Literature DB >> 15995663

Resistance to debate on how to postpone ageing is delaying progress and costing lives. Open discussions in the biogerontology community would attract public interest and influence funding policy.

Aubrey D N J de Grey1.   

Abstract

Mesh：

Year:  2005        PMID： 15995663      PMCID： PMC1369265          DOI： 10.1038/sj.embor.7400399

Source DB:  PubMed          Journal:  EMBO Rep        ISSN： 1469-221X            Impact factor:   8.807


× No keyword cloud information.
  28 in total

1.  Does time spent in hospital in the final 15 years of life increase with age at death? A population based study.

Authors:  R L Himsworth; M J Goldacre
Journal:  BMJ       Date:  1999-11-20

2.  Demography. Prospects for human longevity.

Authors:  S J Olshansky; B A Carnes; A Désesquelles
Journal:  Science       Date:  2001-02-23       Impact factor: 47.728

3.  Extending life: scientific prospects and political obstacles.

Authors:  Richard A Miller
Journal:  Milbank Q       Date:  2002       Impact factor: 4.911

4.  Time to talk SENS: critiquing the immutability of human aging.

Authors:  Aubrey D N J de Grey; Bruce N Ames; Julie K Andersen; Andrzej Bartke; Judith Campisi; Christopher B Heward; Roger J M McCarter; Gregory Stock
Journal:  Ann N Y Acad Sci       Date:  2002-04       Impact factor: 5.691

Review 5.  Subfield history: caloric restriction, slowing aging, and extending life.

Authors:  Edward J Masoro
Journal:  Sci Aging Knowledge Environ       Date:  2003-02-26

Review 6.  The foreseeability of real anti-aging medicine: focusing the debate.

Authors:  Aubrey D N J de Grey
Journal:  Exp Gerontol       Date:  2003-09       Impact factor: 4.032

7.  All hype, no hope? Excessive pessimism in the "anti-aging medicine" special sections.

Authors:  Michael J Rae
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2005-02       Impact factor: 6.053

8.  The p66shc adaptor protein controls oxidative stress response and life span in mammals.

Authors:  E Migliaccio; M Giorgio; S Mele; G Pelicci; P Reboldi; P P Pandolfi; L Lanfrancone; P G Pelicci
Journal:  Nature       Date:  1999-11-18       Impact factor: 49.962

Review 9.  The real Dorian Gray mouse.

Authors:  G J Lithgow; J K Andersen
Journal:  Bioessays       Date:  2000-05       Impact factor: 4.345

Review 10.  An engineer's approach to the development of real anti-aging medicine.

Authors:  Aubrey D N J de Grey
Journal:  Sci Aging Knowledge Environ       Date:  2003-01-08
View more
  5 in total

1.  Like it or not, life-extension research extends beyond biogerontology.

Authors:  Aubrey D N J de Grey
Journal:  EMBO Rep       Date:  2005-11       Impact factor: 8.807

Review 2.  Anticipating the anti-ageing pill. Lessons from the history of the oral contraceptive pill and hormone replacement therapy.

Authors:  Jayne C Lucke; Phillippa C Diedrichs; Bradley Partridge; Wayne D Hall
Journal:  EMBO Rep       Date:  2009-01-16       Impact factor: 8.807

3.  A tale of two strategies. The moral imperative to tackle ageing.

Authors:  Colin Farrelly
Journal:  EMBO Rep       Date:  2008-07       Impact factor: 8.807

Review 4.  Mechanistic links between aging and lung fibrosis.

Authors:  Victor J Thannickal
Journal:  Biogerontology       Date:  2013-08-09       Impact factor: 4.277

5.  Science fact and the SENS agenda. What can we reasonably expect from ageing research?

Authors:  Huber Warner; Julie Anderson; Steven Austad; Ettore Bergamini; Dale Bredesen; Robert Butler; Bruce A Carnes; Brian F C Clark; Vincent Cristofalo; John Faulkner; Leonard Guarente; David E Harrison; Tom Kirkwood; Gordon Lithgow; George Martin; Ed Masoro; Simon Melov; Richard A Miller; S Jay Olshansky; Linda Partridge; Olivia Pereira-Smith; Tom Perls; Arlan Richardson; James Smith; Thomas von Zglinicki; Eugenia Wang; Jeanne Y Wei; T Franklin Williams
Journal:  EMBO Rep       Date:  2005-11       Impact factor: 8.807
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.